NASDAQ · POM

POMDOCTOR LIMITED news

$0.9300+2.20%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About POMDOCTOR LIMITED

Small Chinese Firms Withdraw Wall Street IPO Applications
BenzingaMay 14, 11:20 AM ET▼ Negative

Stock collapsed from $5.42 to $0.50 in December and now trades at $0.13, representing a 97% loss for IPO investors. Cited as a typical example of 'pump and dump' scheme that prompted regulatory crackdown.

POMDOCTOR URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds PomDoctor, Ltd. Investors of the April 7th Lead Plaintiff Deadline and Urges Investors to Contact the Firm
GlobeNewswire Inc.Apr 6, 5:37 PM ET▼ Negative

The company is accused of orchestrating a fraudulent stock promotion scheme involving false statements, undisclosed insider share dumping through offshore accounts, and artificial price inflation driven by social media misinformation. These serious allegations of securities fraud and deceptive practices represent significant legal and reputational risks.

POMDOCTOR DEADLINE: ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages PomDoctor Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action– POM
GlobeNewswire Inc.Apr 5, 9:05 AM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, insider share dumping, false statements, and material omissions regarding business risks. These allegations indicate serious corporate misconduct and investor harm.

POMDOCTOR DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action– POM
GlobeNewswire Inc.Apr 2, 8:02 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false and misleading statements, insider share dumping through offshore accounts, and artificial price inflation. These serious allegations of fraud and market manipulation indicate significant legal and reputational risks.

POM IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action - POM
GlobeNewswire Inc.Mar 30, 3:53 PM ET▼ Negative

Company is subject to securities class action lawsuit alleging fraudulent stock promotion schemes, coordinated insider share dumping, false social media-based misinformation, impersonated financial professionals, and materially misleading public statements about business operations and prospects.

POMDOCTOR DEADLINE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
GlobeNewswire Inc.Mar 27, 11:01 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false and misleading statements, insider share dumping, and artificial trading activity designed to inflate stock prices. These serious allegations of fraud and market manipulation indicate significant legal and reputational risks.

Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)
GlobeNewswire Inc.Mar 24, 8:00 AM ET▼ Negative

Defendant in class action alleging fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals, indicating deliberate deceptive practices.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
GlobeNewswire Inc.Mar 21, 9:52 AM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false statements, insider share dumping through offshore accounts, and artificial price inflation. These serious allegations of fraud and market manipulation indicate significant legal and reputational risks.

ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
GlobeNewswire Inc.Mar 15, 12:49 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false statements, insider share dumping through offshore accounts, and artificial price inflation. These serious allegations of fraud and market manipulation indicate significant legal and reputational risks.

ROSEN, A LONGSTANDING FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
GlobeNewswire Inc.Mar 9, 11:05 PM ET▼ Negative

The company is the subject of a securities class action lawsuit alleging fraudulent stock promotion schemes, false statements, insider share dumping through offshore accounts, and artificial price inflation. These serious allegations of fraud and market manipulation indicate significant legal and reputational risks.

Also mentions POM

Articles that tag POM but are mainly about other companies.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology